- Trials with a EudraCT protocol (49)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
49 result(s) found for: Metabolic Pathway.
Displaying page 1 of 3.
EudraCT Number: 2018-004245-16 | Sponsor Protocol Number: NL67646.068.18 | Start Date*: 2019-04-16 |
Sponsor Name:Maastricht University | ||
Full Title: Targeting the beta-2 adrenergic pathway to improve skeletal muscle glucose uptake in healthy humans | ||
Medical condition: Type 2 diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-000731-31 | Sponsor Protocol Number: NL76746.068.21 | Start Date*: 2021-10-14 |
Sponsor Name:Maastricht University | ||
Full Title: Targeting the beta-2 adrenergic pathway to improve skeletal muscle glucose uptake in obese humans | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001968-35 | Sponsor Protocol Number: SPIROTREAT | Start Date*: 2015-03-11 | |||||||||||
Sponsor Name:Klinikum der Universität München - AöR vertreten durch den Vorstand des Bereiches umanmedizinH | |||||||||||||
Full Title: Add-on spironolactone for the treatment of schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001176-12 | Sponsor Protocol Number: CSPP100A2325 | Start Date*: 2006-01-26 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A randomized, double-blind, double-dummy, parallel-group study to compare the effects of multiple dose administration of aliskiren and irbesartan on biomarkers of inflammation and cardiovascular ri... | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-005006-35 | Sponsor Protocol Number: RM-493-022 | Start Date*: 2018-05-30 |
Sponsor Name:Rhythm Pharmaceuticals, Inc. | ||
Full Title: Long Term Extension Trial of setmelanotide (RM-493) for patients who have completed a trial of Setmelanotide for the treatment of obesity associated with genetic defects upstream of the MC4 recepto... | ||
Medical condition: Patients with obesity caused by genetic defects upstream of the MC4 receptor in the leptin-melanocortin pathway. Human Genetics studies have identified several diseases that are the result of genet... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) FR (Ongoing) NL (Ongoing) GB (GB - no longer in EU/EEA) BE (Ongoing) ES (Ongoing) GR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004999-19 | Sponsor Protocol Number: 191001 | Start Date*: 2020-06-16 | |||||||||||
Sponsor Name:Department of infectious diseases, Hvidovre Hospital | |||||||||||||
Full Title: Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamuvidine compared to continued treatment with dolutegravir/abacavir/lamuvidine for virologically suppress... | |||||||||||||
Medical condition: Human immunodeficiency viruses (HIV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001923-30 | Sponsor Protocol Number: TN-20 | Start Date*: 2016-09-26 | |||||||||||
Sponsor Name:TRIALNET COORDINATING CENTER AT THE UNIVERSITY OF SOUTH FLORIDA | |||||||||||||
Full Title: Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus | |||||||||||||
Medical condition: Type 1 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002998-20 | Sponsor Protocol Number: UNOLE0626 | Start Date*: 2017-10-04 |
Sponsor Name:University of Leicester | ||
Full Title: Effectiveness and cost of integrating a protocol with use of liraglutide 3.0mg into an obesity service (STRIVE Study) | ||
Medical condition: Obesity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2019-003907-37 | Sponsor Protocol Number: DON3 | Start Date*: 2020-09-08 | |||||||||||
Sponsor Name:Università Campus Bio-Medico | |||||||||||||
Full Title: The effects of vitamin D on bone, muscle and adipose tissue: a phase IV randomized double-blind study. | |||||||||||||
Medical condition: Obese elderly patients with vitamin D deficiency who have scheduled either hip replacement due to osteoarthritis or bariatric surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010572-20 | Sponsor Protocol Number: CA198-002 | Start Date*: 2009-10-12 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Phase 1/2 Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-863233 in Subjects with Advanced and/or Metastatic Solid Tumors | |||||||||||||
Medical condition: Advanced and/or metastatic solid tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005626-30 | Sponsor Protocol Number: REACHIN | Start Date*: 2014-01-23 |
Sponsor Name:CUB Erasme Hospital | ||
Full Title: Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (non resectable) and metastatic cholangiocarcinoma: a randomized double-blinded phase II trial. | ||
Medical condition: Locally advanced (non resectable) and metastatic histologically proven intra-hepatic or hilum cholangiocarcinoma + histologically proven metastatic extra-hepatic cholangiocarcinoma (common bile duc... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004486-27 | Sponsor Protocol Number: X31005 | Start Date*: 2018-02-12 |
Sponsor Name:Associació Per a la Recerca Oncològica(APRO) | ||
Full Title: Phase II Study of Paclitaxel and TAK-228 in metastatic urothelial carcinoma (UC) and the impact of PI3K-mTOR pathway genomic alterations | ||
Medical condition: Metastatic urothelial carcinoma (UC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004059-34 | Sponsor Protocol Number: C7Q040 | Start Date*: 2021-02-25 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Stimulation of the beta-2 adrenergic receptor for activating human brown adipose tissue | |||||||||||||
Medical condition: Obesity, overweight, lipid- and glucose metabolism | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002347-41 | Sponsor Protocol Number: CA209-744 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Risk-based, response-adapted, Phase II open-label trial of nivolumab + brentuximab vedotin (N + Bv) for children, adolescents, and young adults with relapsed/refractory (R/R) CD30 + classic Hodgkin... | |||||||||||||
Medical condition: Relapsed/refractory (R/R) CD30 + classic Hodgkin lymphoma (cHL) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Ongoing) IE (Ongoing) DE (Ongoing) GB (GB - no longer in EU/EEA) NL (Ongoing) PL (Completed) Outside EU/EEA IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003700-31 | Sponsor Protocol Number: ImNuT | Start Date*: 2017-10-11 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Effects of nutrition therapy on growth, metabolism and inflammation in immature infants; a double-blind randomized, controlled trial | ||
Medical condition: To determine whether early and prolonged supply of ARA and DHA improves quality of growth and clinical outcomes in extreme premature infants as compared to our present nutrient supply. By closely a... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003718-18 | Sponsor Protocol Number: CCR3689 | Start Date*: 2012-02-09 |
Sponsor Name:Royal Marsden Hospital NHS Foundation Trust | ||
Full Title: Proof-of-concept study of AZD 4547 in patients with FGFR1 or FGFR2 amplified tumours | ||
Medical condition: Advanced Breast Cancer Advanced Lung Cancer Advanced Upper gastrointestinal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004550-28 | Sponsor Protocol Number: AIO-NET-0112 | Start Date*: 2015-03-12 |
Sponsor Name:AIO-Studien-gGmbH | ||
Full Title: EVINEC: Safety and Tolerability of Everolimus as second-line treatment in poorly differentiated neuroendocrine carcinoma / neuroendocrine carcinoma G3 according to WHO 2010 and neuroendocrine tumor... | ||
Medical condition: • Poorly differentiated neuroendocrine carcinoma, neuroendocrine carcinoma G3 (NEC G3 according to WHO 2010) with primary tumor outside lung • Well to moderately differentiated neuroendocrine carci... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002074-46 | Sponsor Protocol Number: FIONA | Start Date*: 2013-08-02 | |||||||||||
Sponsor Name:Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione “G.Pascale” | |||||||||||||
Full Title: Multicentre, two-stage, phase 2 study of neoadjuvant FOLFIRINOX followed by chemo-IMRT in patients with locally advanced unresectable pancreatic cancer | |||||||||||||
Medical condition: Locally advanced unresectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005961-16 | Sponsor Protocol Number: QVID-001 | Start Date*: 2021-02-05 | |||||||||||
Sponsor Name:Lars Jørgen Østergaard | |||||||||||||
Full Title: Coenzyme Q10 as treatment for Long Term COVID-19 (The QVID study) | |||||||||||||
Medical condition: Long Term COVID-19 illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000665-36 | Sponsor Protocol Number: UZB-MO-FC-01 | Start Date*: 2013-10-16 | |||||||||||
Sponsor Name:UZ Brussel | |||||||||||||
Full Title: A phase II, open label study of everolimus with fulvestrant in postmenopausal women with hormone receptor-positive HER-2 negative AI and fulvestrant treated, locally advanced or metastatic breast c... | |||||||||||||
Medical condition: postmenopausal women with hormone receptor-positive, Her2 negative AI and fulvestrant treated, locally advanced or metastatic breast cancer, who progressed on prior fulvestrant and also received pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.